Semaglutide and tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance from European Association for the Study of Obesity (EASO) Semaglutide and tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance from European Association for the Study of Obesity (EASO) Research
Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity Policy, Research
easo.org easo.org Childhood Obesity Task Force Position Statement – Childhood Obesity is a Disease guideline
karger.com karger.com The Ethics of Childhood Obesity Treatment – from the Childhood Obesity Task Force (COTF) of European Association for the Study of Obesity (EASO) guideline
karger.com karger.com An EASO Position Statement on Multidisciplinary Obesity Management in Adults guideline
karger.com karger.com Need for a Paradigm Shift in Adult Overweight and Obesity Management – an EASO Position Statement on a Pressing public Health, Clinical and Scientific Challenge in Europe guideline
easo.org easo.org Obesity: The Gateway to Ill Health – an EASO Position Statement on a Rising Public Health, Clinical and Scientific Challenge in Europe guideline
